Nasdaq

Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...
Nasdaq

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
Hosted on MSN

FDA approves Medtronic’s urinary incontinence treatment device

The US Food and Drug Administration (FDA) has approved Medtronic’s Altaviva device, intended for the treatment of urge urinary incontinence. This implantable tibial neuromodulation (ITNM) device ...
Business Wire

Minze Health Announces Collaboration with Medtronic to Support Patients with Overactive Bladder in EMEA

Under this partnership, the Minze Diary Pod – an automated bladder diary solution – will be offered as part of the SNM care pathway, enabling clinicians and patients to gather richer, more objective ...
zacks

Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?

Medtronic secured FDA approval for its Altaviva implantable tibial neuromodulation device. MDT's device treats urge urinary incontinence through a minimally invasive ankle implant. MDT's Altaviva ...